AstraZeneca stock jumps after surprise lung disease trial win

AstraZeneca‘s stock rose over 3% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable shift…

Read More

Stoxx 600, FTSE, DAX, CAC, Iran news and oil prices

The Iran-flagged container vessel “Nora”, in Kalundborg harbor, Denmark, March 18, 2026. The vessel was detained by Denmark’s maritime authority in February over registration concerns. Jens Nielsen | Via Reuters LONDON — European stocks followed Asian markets sharply lower at the start of the new trading week, as further escalation in the Iran war drags…

Read More